Co-Authors
This is a "connection" page, showing publications co-authored by Eldad Hod and Sarah Borden.
Connection Strength
0.111
-
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 06 16; 21(1):536.
Score: 0.055
-
Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 06 08; 21(1):499.
Score: 0.055